National Cancer Institute; Notice of Meeting, 75423 [2016-26130]

Download as PDF Federal Register / Vol. 81, No. 210 / Monday, October 31, 2016 / Notices Dated: October 25, 2016. John D. Hewes, Technology Transfer Specialist, Technology Transfer Center, National Cancer Institute. [FR Doc. 2016–26129 Filed 10–28–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting sradovich on DSK3GMQ082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App. 2), notice is hereby given of the joint meeting of the National Cancer Advisory Board (NCAB) and NCI Board of Scientific Advisors (BSA). The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting Web site (http:// videocast.nih.gov). A portion of the National Cancer Advisory Board meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended, for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Cancer Institute, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board; Ad Hoc Subcommittee on Global Cancer Research. Open: December 5, 2016, 4:30 p.m. to 6:00 p.m. Agenda: Discussion on Global Cancer Research. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washington Boulevard, Lakeside 1 Meeting Room, Gaithersburg, MD 20878. Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad Hoc Subcommittee on Global Cancer Research, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 3W562, Bethesda, MD 20892, (240) 276–5796, trimblet@ mail.nih.gov. VerDate Sep<11>2014 17:53 Oct 28, 2016 Jkt 241001 Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Open: December 6, 2016, 8:30 a.m. to 4:00 p.m. Agenda: Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors; NCI Board of Scientific Advisors Concepts Review, NCI acting Director’s report and presentations. Closed: December 6, 2016, 4:00 p.m. to 5:30 p.m. Agenda: Review of intramural program site visit outcomes and the discussion of confidential personnel issues. Open: December 7, 2016, 9:00 a.m. to 12:00 p.m. Agenda: Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors and presentations. Place: National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room TE406, Bethesda, MD 20892. Contact Person: Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892, 240–276–6340, grayp@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NCI—Shady Grove campus. All visitors will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: NCAB: http:// deainfo.nci.nih.gov/advisory/ncab/ncab.htm, BSA: http://deainfo.nci.nih.gov/advisory/ bsa/bsa.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: October 25, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–26130 Filed 10–28–16; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 75423 DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [Docket No. USCBP–2016–0066] Commercial Customs Operations Advisory Committee (COAC) U.S. Customs and Border Protection (CBP), Department of Homeland Security (DHS). ACTION: Committee Management; Notice of Federal Advisory Committee Meeting. AGENCY: The Commercial Customs Operations Advisory Committee (COAC) will meet in Washington, DC. The meeting will be open to the public. DATES: The Commercial Customs Operations Advisory Committee (COAC) will meet on Thursday, November 17, 2016, from 12:30 p.m. to 4:30 p.m. EST. Please note that the meeting may close early if the committee has completed its business. Pre-Registration: Meeting participants may attend either in person or via webinar after pre-registering using a method indicated below: —For members of the public who plan to attend the meeting in person, please register by 5:00 p.m. EST by November 15, 2016 either online at https://apps.cbp.gov/te_reg/ index.asp?w=97 by email to tradeevents@dhs.gov; or by fax to (202) 325–4290. You must register prior to the meeting in order to attend the meeting in person. —For members of the public who plan to participate via webinar, please register online at https:// apps.cbp.gov/te_reg/index.asp?w=96 by 5:00 p.m. EST by November 15, 2016. Please feel free to share this information with other interested members of your organization or association. Members of the public who are preregistered and later need to cancel, please do so in advance of the meeting by accessing one (1) of the following links: https://apps.cbp.gov/te_reg/ cancel.asp?w=97 to cancel an in person registration, or https://apps.cbp.gov/te_ reg/cancel.asp?w=96 to cancel a webinar registration. ADDRESSES: The meeting will be held at the Washington Marriott Wardman Park Hotel, 2660 Woodley Road NW., Washington, DC 20008. There will be signage posted directing visitors to the location of the meeting room. For information on facilities or services for individuals with disabilities or to request special assistance at the meeting, contact Ms. Karmeshia Tuck, SUMMARY: E:\FR\FM\31OCN1.SGM 31OCN1

Agencies

[Federal Register Volume 81, Number 210 (Monday, October 31, 2016)]
[Notices]
[Page 75423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26130]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App. 2), notice is hereby given of the joint meeting 
of the National Cancer Advisory Board (NCAB) and NCI Board of 
Scientific Advisors (BSA).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
Web site (http://videocast.nih.gov).
    A portion of the National Cancer Advisory Board meeting will be 
closed to the public in accordance with the provisions set forth in 
section 552b(c)(6), Title 5 U.S.C., as amended, for the review, 
discussion, and evaluation of individual intramural programs and 
projects conducted by the National Cancer Institute, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board; Ad Hoc 
Subcommittee on Global Cancer Research.
    Open: December 5, 2016, 4:30 p.m. to 6:00 p.m.
    Agenda: Discussion on Global Cancer Research.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washington Boulevard, Lakeside 1 Meeting Room, Gaithersburg, MD 
20878.
    Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad 
Hoc Subcommittee on Global Cancer Research, National Cancer 
Institute--Shady Grove, National Institutes of Health, 9609 Medical 
Center Drive, Room 3W562, Bethesda, MD 20892, (240) 276-5796, 
trimblet@mail.nih.gov.

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Open: December 6, 2016, 8:30 a.m. to 4:00 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors; NCI Board of Scientific Advisors 
Concepts Review, NCI acting Director's report and presentations.
    Closed: December 6, 2016, 4:00 p.m. to 5:30 p.m.
    Agenda: Review of intramural program site visit outcomes and the 
discussion of confidential personnel issues.
    Open: December 7, 2016, 9:00 a.m. to 12:00 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors and presentations.
    Place: National Cancer Institute--Shady Grove, National 
Institutes of Health, 9609 Medical Center Drive, Room TE406, 
Bethesda, MD 20892.
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, Room 
7W444, Bethesda, MD 20892, 240-276-6340, grayp@mail.nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NCI--Shady Grove campus. All 
visitors will be asked to show one form of identification (for 
example, a government-issued photo ID, driver's license, or 
passport) and to state the purpose of their visit. Information is 
also available on the Institute's/Center's home page: NCAB: http://deainfo.nci.nih.gov/advisory/ncab/ncab.htm, BSA: http://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 25, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-26130 Filed 10-28-16; 8:45 am]
 BILLING CODE 4140-01-P